Tildrakizumab Promising for Psoriasis in Patients with PsA
Scottish Medicines Consortium Recommends Risankizumab; Plus Real-World Data on Secukinumab
Japan Approves Risankizumab for Psoriasis & Psoriatic Arthritis
For Psoriasis, Ustekinumab & TNF Inhibitors Show Similar Cardiac Safety
Patients with Psoriatic Arthritis at Increased Risk for Type 2 Diabetes
Piclidenoson in Trials for Psoriasis & RA; Plus Duzallo Approved in Europe
Adalimumab Appears Safe for Treating Pediatric Patients with Autoimmune Disease
Dietary Recommendations for Psoriasis Patients
Certolizumab Pegol Receives FDA Approval for Plaque Psoriasis
- 1
- 2
- 3
- …
- 7
- Next Page »